Share This Page
Drug Price Trends for DOCUSATE CAL
✉ Email this page to a colleague

Average Pharmacy Cost for DOCUSATE CAL
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
DOCUSATE CAL 240 MG SOFTGEL | 00904-6997-40 | 0.05086 | EACH | 2025-01-22 |
DOCUSATE CAL 240 MG SOFTGEL | 00904-6997-60 | 0.05086 | EACH | 2025-01-22 |
DOCUSATE CAL 240 MG SOFTGEL | 00904-6997-80 | 0.05086 | EACH | 2025-01-22 |
DOCUSATE CAL 240 MG SOFTGEL | 00904-6997-40 | 0.05196 | EACH | 2024-12-18 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Docusate Sodium Market Analysis and Price Projections
Market Overview
Docusate sodium, a staple in the treatment of constipation and other digestive disorders, is experiencing significant growth driven by several key factors. Here’s a comprehensive analysis of the market, including its current state, future projections, and pricing insights.
Market Size and Growth Projections
The global docusate sodium market is anticipated to exhibit robust growth over the coming years. According to recent forecasts, the market is expected to reach $12 million by 2033, growing at a Compound Annual Growth Rate (CAGR) of 8.5% from 2025 to 2033[2].
Another projection suggests that the market could reach as high as $21.51 billion by 2033, with a CAGR of 4.42% from 2023 to 2033. This discrepancy highlights the varying estimates but underscores the consistent expectation of significant growth[3].
Drivers of Market Growth
Increasing Prevalence of Digestive Disorders
The growing incidence of constipation and other digestive disorders is a major driver of the docusate sodium market. Approximately 16% of adults suffer from constipation, and this number is expected to rise, particularly among the aging population[3].
Growing Geriatric Population
The global population aged 60 and above is projected to reach 2 billion by 2050, more than triple the number in 2000. This demographic shift is driving the demand for medications that manage age-related health issues such as constipation[3].
Preference for Non-Stimulant Laxatives
Consumers increasingly prefer docusate sodium over stimulant laxatives due to its gentler and less addictive nature. This preference is contributing to the market's growth[2].
Advancements in Formulation Technology
Novel formulations, such as delayed-release capsules and taste-masked tablets, enhance patient convenience and adherence, further boosting the market[2].
Market Segmentation
By Application
The market is segmented into two primary applications: excipients and active pharmaceutical ingredients (APIs). The API segment is expected to dominate the market due to increased usage in over-the-counter and prescription medications[2][3].
By Type
Docusate sodium is available in various concentrations, including DSS 100%, DSS 85%, and DSS 50%. The choice of concentration depends on the intended application and dosage form[2].
By Region
North America and Europe are the largest markets for docusate sodium, driven by the high prevalence of digestive disorders and well-established healthcare systems. Asia-Pacific is expected to witness significant growth due to the rising incidence of chronic diseases and increasing adoption of Western lifestyles[2][3].
Key Players and Market Strategies
Key players in the market include Cytec Industries, Laxachem, Aqualax, Calube, Colace, and Hunan Warrant Pharmaceutical. These companies are focusing on product innovation, strategic partnerships, and geographical expansion to maintain their competitive edge[1][2].
Pricing and Cost Analysis
The cost of docusate sodium varies based on the dosage form and quantity. For example, a supply of 12 docusate sodium 100 mg oral capsules can cost around $10, with the price per unit decreasing as the quantity increases[5].
Quantity | Per Unit | Price |
---|---|---|
12 | $0.81 | $9.70 |
14 | $0.70 | $9.74 |
25 | $0.40 | $9.92 |
30 | $0.33 | $10.01 |
For higher quantities, such as 100 capsules of docusate sodium 240 mg, the price can range from $14.86[5].
Impact of COVID-19
The COVID-19 pandemic has had a significant impact on the docusate sodium market, causing disruptions in the supply chain and affecting production and distribution. However, as the world recovers from the pandemic, the demand for docusate sodium is expected to rise, driven by the increasing incidence of digestive disorders and the growing geriatric population[3].
Market Dynamics
Drivers
- Growing Incidence of Digestive Disorders: Constipation and other digestive issues are becoming more prevalent, driving the demand for docusate sodium.
- Growing Geriatric Population: The aging population is more susceptible to constipation and other digestive problems.
- Advancements in Formulation Technology: New formulations enhance patient convenience and adherence.
- Pharmaceutical Industry Expansion: The expansion of the pharmaceutical industry drives demand for docusate sodium as an excipient and API[2][3].
Challenges
- Supply Chain Disruptions: The COVID-19 pandemic has caused shortages and delays in the supply chain.
- Regulatory Factors: Government policies and regulatory changes can impact market dynamics.
Regional Analysis
North America
The North American market is driven by the high prevalence of digestive disorders and a growing geriatric population. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an estimated 60 to 70 million people in the United States are affected by digestive diseases[3].
Europe
The European market is also driven by the high prevalence of digestive disorders and the aging population. The European Society for Primary Care Gastroenterology (ESPCG) estimates that approximately 25% of the European population suffers from digestive disorders[3].
Asia-Pacific
Asia-Pacific is expected to witness significant growth due to the rising incidence of chronic diseases, the increasing adoption of Western lifestyles, and growing disposable income levels[2].
Product Insights
Docusate sodium is available in various dosage forms, including tablets, capsules, and liquids. The dosage strength ranges from 50 mg to 240 mg per unit. It is often combined with other laxatives for enhanced efficacy[2].
Key Takeaways
- The global docusate sodium market is projected to grow significantly, driven by the increasing prevalence of digestive disorders and the growing geriatric population.
- North America and Europe are the dominant regional markets, with Asia-Pacific expected to show significant growth.
- The API segment is expected to dominate the market due to increased usage in over-the-counter and prescription medications.
- Key players are focusing on product innovation, strategic partnerships, and geographical expansion.
FAQs
What is the projected market size of docusate sodium by 2033?
The global docusate sodium market is projected to reach $12 million by 2033, with a CAGR of 8.5% from 2025 to 2033, or as high as $21.51 billion with a CAGR of 4.42% from 2023 to 2033[2][3].
What are the primary drivers of the docusate sodium market?
The primary drivers include the growing incidence of digestive disorders, the growing geriatric population, preference for non-stimulant laxatives, and advancements in formulation technology[2][3].
Which regions are expected to dominate the docusate sodium market?
North America and Europe are currently the largest markets, with Asia-Pacific expected to show significant growth in the future[2][3].
What are the different types of docusate sodium available?
Docusate sodium is available in various concentrations, including DSS 100%, DSS 85%, and DSS 50%[2].
How does the COVID-19 pandemic impact the docusate sodium market?
The pandemic has caused supply chain disruptions and affected production and distribution, but the demand is expected to rise as the world recovers from the pandemic[3].
Sources
- HTF Market Intelligence: "Global Docusate Sodium Market Study"
- Data Insights Market: "Docusate Sodium 2024 Market Trends and 2032 Forecasts"
- Evolve Business Intelligence: "Docusate Sodium Market Analysis and Global Forecast 2023-2033"
- Emergen Research: "Stool Softener Industry Trend, Forecast [2021-2030]"
- Drugs.com: "Docusate Prices, Coupons, Copay Cards & Patient Assistance"
More… ↓